ASTERIAS BIOTHERAPEUTICS, INC.

Profile

Company Names

ASTERIAS BIOTHERAPEUTICS, INC.

Addresses

230 CONSTITUTION DRIVE, MENLO PARK, CA 94025

Phone Numbers

510-521-3390

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$4,936,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2015-02-09 
$4,000,000.00 
$4,000,000.00 
$0.00 
Equity 
2
2014-06-16 
$0.00 
$11,700,000.00 
$11,700,000.00 
 
1
2014-06-09 
$936,000.00 
$3,276,000.00 
$2,340,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANDREW 
 
ARNO 
DIRECTOR
UNTERBERG TECHNOLOGY PARTNERS, L.P.   |  MERRIMAN CURHAN FORD GROUP, INC.   |  SMITH MICRO SOFTWARE INC   |  ASTERIAS BIOTHERAPEUTICS, INC.   |  ONCOCYTE CORP   |  COMHEAR, INC.   |  SMITH MICRO SOFTWARE, INC   |  INDEPENDA, INC.   |  SMITH MICRO SOFTWARE, INC.
ALFRED 
D 
KINGSLEY 
DIRECTOR
BIOTIME INC   |  RECYTE THERAPEUTICS, INC.   |  ASTERIAS BIOTHERAPEUTICS, INC.   |  ONCOCYTE CORP
JANE 
S 
LEBKOWSKI 
EXECUTIVE OFFICER
ASTERIAS BIOTHERAPEUTICS, INC.
RICHARD 
T 
LEBUHN 
DIRECTOR
ASTERIAS BIOTHERAPEUTICS, INC.
RICHARD 
T. 
LEBUHN 
DIRECTOR
COMARCO INC   |  ASTERIAS BIOTHERAPEUTICS, INC.
PEDRO 
 
LICHTINGER 
EXECUTIVE OFFICER, DIRECTOR
VELCERA, INC.   |  BIOTIME INC   |  ASTERIAS BIOTHERAPEUTICS, INC.   |  GEMPHIRE THERAPEUTICS INC.   |  CHEMIOCARE INC.   |  STARTON THERAPEUTICS INC.
ROBERT 
W 
PEABODY 
EXECUTIVE OFFICER, DIRECTOR
BIOTIME INC   |  ASTERIAS BIOTHERAPEUTICS, INC.
NATALE 
 
RICCIARDI 
DIRECTOR
ASTERIAS BIOTHERAPEUTICS, INC.   |  RAPID MICRO BIOSYSTEMS, INC.
JUDITH 
 
SEGALL 
DIRECTOR, EXECUTIVE OFFICER
BIOTIME INC   |  RECYTE THERAPEUTICS, INC.   |  ASTERIAS BIOTHERAPEUTICS, INC.   |  PHYTHERA THERAPEUTICS INC.
KATHARINE 
 
SPINK 
EXECUTIVE OFFICER
ASTERIAS BIOTHERAPEUTICS, INC.
MICHAEL 
D 
WEST 
EXECUTIVE OFFICER, DIRECTOR
BIOTIME INC   |  RECYTE THERAPEUTICS, INC.   |  ASTERIAS BIOTHERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-02-23
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-02-09 
2014-06-20
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
 
2014-06-16 
2014-06-19
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Equity 
2014-06-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#